Simplex Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Simplex Trading’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-67	Closed	-$2K	–	7298
2016 Q3	$2K	Buy	67 +33	+97%	+$65	﹤0.01%	5205
2016 Q2	$1K	Buy	34 +21	+162%	+$40	﹤0.01%	5707
2016 Q1	$2K	Sell	13 -98	-88%	-$96	﹤0.01%	4978
2015 Q4	$69K	Buy	111 +18	+19%	+$58	0.01%	1663
2015 Q3	$34K	Buy	93 +80	+615%	+$612	﹤0.01%	2313
2015 Q2	$13K	Hold	13	–	–	﹤0.01%	2890
2015 Q1	$12K	Sell	13 -471	-97%	-$4.21K	﹤0.01%	2848
2014 Q4	$37K	Buy	+484	New	+$4.13K	﹤0.01%	1593

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's RPRX Position: Q2 2017 in Review

Simplex Trading sold out of Repros Therapeutics Inc. (RPRX) in Q2 2017, closing a stake of 2,985 shares — an estimated $2.17K sold.

Simplex Trading first reported a position in RPRX in Q4 2014 and held it in 7 quarters. The position peaked at $208K in Q4 2014. 29 funds tracked by Wall St. Rank hold RPRX as of Q2 2017.

Simplex Trading reported no remaining Repros Therapeutics Inc. position as of Q2 2017 after selling out during the quarter.
Simplex Trading sold 2,985 Repros Therapeutics Inc. shares in Q2 2017, an estimated $2.17K.
Simplex Trading first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 7 quarters.
Simplex Trading's Repros Therapeutics Inc. position peaked at $208K in Q4 2014.
29 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2017.

Based on Simplex Trading's 13F filing for Q2 2017, filed 12 Jul 2017.